Abstract HPV self-sampling (HPV-SS) can increase cervical cancer screening participation
by addressing barriers in high-and low-and middle-income settings. Successful …

Introduction Human papillomavirus (HPV) self-sampling test kits may increase screening for
and early detection of cervical cancer and reduce its burden globally. To inform WHO self …

Objectives A meta-analysis was conducted to examine the effectiveness of HPV self-
sampling proposal on cervical cancer screening (CCS) uptake when compared with an …

Objective To provide a focused critical review of the literature on the acceptability, feasibility,
and uptake of human papillomavirus (HPV) self-sampling among hard-to-reach women …

Introduction The WHO recommends human papillomavirus (HPV) cervical self-sampling as
an additional screening method and HPV DNA testing as an effective approach for the early …

In 2016, the Netherlands will switch, as first European country, from cytology-based to HPV-
based cervical cancer screening, with cytology triage for those with a positive HPV test. The …

An increasing body of evidence supports the validity of self-sampling as an alternative to
clinician collection for primary Human Papillomavirus (HPV) screening. Self-sampling …

Background Cervical cancer screening participation remains insufficient in most countries.
Our aim was to evaluate whether offering a HPV self-sampling kit, either mailed directly to …

Background Most cervical cancer in the USA occurs in under-screened women. The My
Body, My Test-3 (MBMT-3) trial sought to assess the efficacy of mailed human …

Background Cervical cancer is the fourth most common cancer affecting women worldwide,
with 85% of the burden estimated to occur among women in low and middle-income …